Table 14.8

De Novo Post Transplant Solid Malignancy, 1997 to 2006

Malignancies by Type	Year of Transplant
Malignancies by Type	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006
Total # of Post-Tx Malignancies	272	287	277	207	201	206	146	156	133	49
Squamous/Basal Cell Carcinoma	110	109	105	86	76	73	47	48	44	12
Melanoma	9	5	13	2	3	6	4	2	10	4
Kaposi Sarcoma	-	-	5	2	1	2	-	1	-	-
Central Nervous System	1	5	-	1	3	2	1	2	-	1
Genito-Urinary (1)	27	37	20	24	21	12	14	11	7	5
Gastro-Intestinal (2)	38	42	37	21	24	15	18	16	14	6
Primary Hepatic Tumor	5	13	12	13	7	16	10	12	14	2
Metastatic Hepatic Tumor	9	12	5	7	10	14	11	10	11	5
Larynx/Bronchi/Lung	36	42	38	27	32	35	18	31	16	7
Breast/Thyroid	13	5	15	5	8	9	5	6	6	3
Leukemia	3	3	-	-	1	2	3	3	1	-
Sarcoma (3)	-	-	1	1	-	2	3	2	1	-
Other	14	11	17	15	9	16	10	9	8	4
Unknown	7	3	9	3	6	2	2	3	1	-
Squamous/Basal Cell Carcinoma	40.4%	38.0%	37.9%	41.5%	37.8%	35.4%	32.2%	30.8%	33.1%	24.5%
Melanoma	3.3%	1.7%	4.7%	1.0%	1.5%	2.9%	2.7%	1.3%	7.5%	8.2%
Kaposi Sarcoma	-	-	1.8%	1.0%	0.5%	1.0%	-	0.6%	-	-
Central Nervous System	0.4%	1.7%	-	0.5%	1.5%	1.0%	0.7%	1.3%	-	2.0%
Genito-Urinary (1)	9.9%	12.9%	7.2%	11.6%	10.4%	5.8%	9.6%	7.1%	5.3%	10.2%
Gastro-Intestinal (2)	14.0%	14.6%	13.4%	10.1%	11.9%	7.3%	12.3%	10.3%	10.5%	12.2%
Primary Hepatic Tumor	1.8%	4.5%	4.3%	6.3%	3.5%	7.8%	6.8%	7.7%	10.5%	4.1%
Metastatic Hepatic Tumor	3.3%	4.2%	1.8%	3.4%	5.0%	6.8%	7.5%	6.4%	8.3%	10.2%
Larynx/Bronchi/Lung	13.2%	14.6%	13.7%	13.0%	15.9%	17.0%	12.3%	19.9%	12.0%	14.3%
Breast/Thyroid	4.8%	1.7%	5.4%	2.4%	4.0%	4.4%	3.4%	3.8%	4.5%	6.1%
Leukemia	1.1%	1.0%	-	-	0.5%	1.0%	2.1%	1.9%	0.8%	-
Sarcoma (3)	-	-	0.4%	0.5%	-	1.0%	2.1%	1.3%	0.8%	-
Other	5.1%	3.8%	6.1%	7.2%	4.5%	7.8%	6.8%	5.8%	6.0%	8.2%
Unknown	2.6%	1.0%	3.2%	1.4%	3.0%	1.0%	1.4%	1.9%	0.8%	-
Total # of Patients	200	208	207	171	161	168	124	125	102	42